141 related articles for article (PubMed ID: 23672243)
1. Does transient hypothyroxinemia influence metabolic bone disease of prematurity?
Demirel U; Özek E; Bereket A; Demirel B; Topuzoğlu A; Akman İ
J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1844-9. PubMed ID: 23672243
[TBL] [Abstract][Full Text] [Related]
2. Transient hypothyroxinemia of prematurity is associated with abnormal cranial ultrasound and illness severity.
Huang CB; Chen FS; Chung MY
Am J Perinatol; 2002 Apr; 19(3):139-47. PubMed ID: 12012289
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Metabolic Bone Disease of Prematurity: Is Hypothyroxinemia Included?
Dursun M; Ozcabi B; Sariaydin M
Sisli Etfal Hastan Tip Bul; 2022; 56(1):84-90. PubMed ID: 35515963
[TBL] [Abstract][Full Text] [Related]
4. The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates.
Kelleher AS; Clark RH; Steinbach M; Chace DH; Spitzer AR;
J Perinatol; 2008 Apr; 28(4):270-4. PubMed ID: 18288119
[TBL] [Abstract][Full Text] [Related]
5. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
[TBL] [Abstract][Full Text] [Related]
6. No Association Between Transient Hypothyroxinemia of Prematurity and Neurodevelopmental Outcome in Young Adulthood.
Hollanders JJ; Israëls J; van der Pal SM; Verkerk PH; Rotteveel J; Finken MJ;
J Clin Endocrinol Metab; 2015 Dec; 100(12):4648-53. PubMed ID: 26480285
[TBL] [Abstract][Full Text] [Related]
7. Clinical indicators that influence a clinician's decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia.
Yilmaz A; Ozer Y; Kaya N; Cakir AD; Culpan HC; Perk Y; Vural M; Evliyaoglu O
Ital J Pediatr; 2023 Aug; 49(1):105. PubMed ID: 37644575
[TBL] [Abstract][Full Text] [Related]
8. Metabolic bone disease and bone mineral density in very preterm infants.
Figueras-Aloy J; Álvarez-Domínguez E; Pérez-Fernández JM; Moretones-Suñol G; Vidal-Sicart S; Botet-Mussons F
J Pediatr; 2014 Mar; 164(3):499-504. PubMed ID: 24331689
[TBL] [Abstract][Full Text] [Related]
9. Transient hypothyroxinemia of prematurity and histological chorioamnionitis.
De Felice C; Bagnoli F; Toti P; Musarò MA; Peruzzi L; Paffetti P; Latini G
J Perinat Med; 2005; 33(6):514-8. PubMed ID: 16318614
[TBL] [Abstract][Full Text] [Related]
10. The relationship between thyroxine level and short term clinical outcome among sick newborn infants.
Kadivar M; Parsaei R; Setoudeh A
Acta Med Iran; 2011; 49(2):93-7. PubMed ID: 21598217
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of metabolic bone disease of prematurity.
Ukarapong S; Venkatarayappa SKB; Navarrete C; Berkovitz G
Early Hum Dev; 2017 Sep; 112():29-34. PubMed ID: 28683339
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes.
Avila-Alvarez A; Urisarri A; Fuentes-Carballal J; Mandiá N; Sucasas-Alonso A; Couce ML
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33321828
[TBL] [Abstract][Full Text] [Related]
14. The effect of thyroid functions on osteopenia of prematurity in preterm infants.
Çakır U; Tayman C
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):65-70. PubMed ID: 30511932
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of transient hypothyroxinemia of prematurity: a prospective cohort study.
Maneenil G; Juthong M; Thatrimontrichai A; Janjindamai W; Dissaneevate S; Jaruratanasirikul S
Turk J Pediatr; 2023; 65(4):562-571. PubMed ID: 37661671
[TBL] [Abstract][Full Text] [Related]
16. Metabolic bone disease: a continued challenge in extremely low birth weight infants.
Viswanathan S; Khasawneh W; McNelis K; Dykstra C; Amstadt R; Super DM; Groh-Wargo S; Kumar D
JPEN J Parenter Enteral Nutr; 2014 Nov; 38(8):982-90. PubMed ID: 23963689
[TBL] [Abstract][Full Text] [Related]
17. The factors associated with transient hypothyroxinemia of prematurity.
Yilmaz A; Ozer Y; Kaya N; Turan H; Acar HC; Ercan O; Perk Y; Evliyaoglu O; Vural M
BMC Pediatr; 2021 Aug; 21(1):344. PubMed ID: 34388993
[TBL] [Abstract][Full Text] [Related]
18. Transient hypothyroxinemia of prematurity and its risk factors in an extramural neonatal intensive care unit.
Rai R; Singh DK; Bhakhri BK
Arch Endocrinol Metab; 2021 Nov; 65(6):723-729. PubMed ID: 33909379
[TBL] [Abstract][Full Text] [Related]
19. Metabolic bone disease of prematurity and secondary hyperparathyroidism.
Lothe A; Sinn J; Stone M
J Paediatr Child Health; 2011 Aug; 47(8):550-3. PubMed ID: 21392146
[TBL] [Abstract][Full Text] [Related]
20. [Osteopenia of prematurity--prophylaxis, diagnostics and treatment].
Hitrova S; Slancheva B; Popivanova A; Vakrilova L; Pramatarova T; Emilova Z; Yarakova N
Akush Ginekol (Sofiia); 2012; 51(7):24-30. PubMed ID: 23610914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
